HAMILTON LANE INC-CLASS A (HLNE)

US4074971064 - Common Stock

154.09  +3.51 (+2.33%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to HLNE. HLNE was compared to 220 industry peers in the Capital Markets industry. HLNE gets an excellent profitability rating and is at the same time showing great financial health properties. HLNE shows excellent growth, but is valued quite expensive already. This makes HLNE very considerable for growth and quality investing!



8

1. Profitability

1.1 Basic Checks

HLNE had positive earnings in the past year.
In the past year HLNE had a positive cash flow from operations.
Each year in the past 5 years HLNE has been profitable.
In the past 5 years HLNE always reported a positive cash flow from operatings.

1.2 Ratios

HLNE has a better Return On Assets (12.76%) than 91.71% of its industry peers.
HLNE has a better Return On Equity (29.97%) than 95.85% of its industry peers.
The Return On Invested Capital of HLNE (22.22%) is better than 96.77% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HLNE is significantly above the industry average of 6.99%.
The 3 year average ROIC (19.34%) for HLNE is below the current ROIC(22.22%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 12.76%
ROE 29.97%
ROIC 22.22%
ROA(3y)10.77%
ROA(5y)10.68%
ROE(3y)32.12%
ROE(5y)34.97%
ROIC(3y)19.34%
ROIC(5y)20.09%

1.3 Margins

The Profit Margin of HLNE (28.03%) is better than 70.05% of its industry peers.
In the last couple of years the Profit Margin of HLNE has grown nicely.
Looking at the Operating Margin, with a value of 45.03%, HLNE is in the better half of the industry, outperforming 75.58% of the companies in the same industry.
In the last couple of years the Operating Margin of HLNE has remained more or less at the same level.
Industry RankSector Rank
OM 45.03%
PM (TTM) 28.03%
GM N/A
OM growth 3Y-0.86%
OM growth 5Y1.44%
PM growth 3Y-2.38%
PM growth 5Y13.8%
GM growth 3YN/A
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

The number of shares outstanding for HLNE has been increased compared to 1 year ago.
HLNE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for HLNE has been reduced compared to a year ago.

2.2 Solvency

HLNE has an Altman-Z score of 7.62. This indicates that HLNE is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 7.62, HLNE belongs to the best of the industry, outperforming 94.01% of the companies in the same industry.
HLNE has a debt to FCF ratio of 1.12. This is a very positive value and a sign of high solvency as it would only need 1.12 years to pay back of all of its debts.
HLNE's Debt to FCF ratio of 1.12 is amongst the best of the industry. HLNE outperforms 86.64% of its industry peers.
HLNE has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of HLNE (0.32) is better than 76.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 1.12
Altman-Z 7.62
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.92 indicates that HLNE may have some problems paying its short term obligations.
The Current ratio of HLNE (0.92) is comparable to the rest of the industry.
HLNE has a Quick Ratio of 0.92. This is a bad value and indicates that HLNE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.92, HLNE is in line with its industry, outperforming 42.40% of the companies in the same industry.
The current and quick ratio evaluation for HLNE is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.92

7

3. Growth

3.1 Past

HLNE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.03%, which is quite impressive.
Measured over the past years, HLNE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.47% on average per year.
HLNE shows a strong growth in Revenue. In the last year, the Revenue has grown by 31.89%.
HLNE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.04% yearly.
EPS 1Y (TTM)45.03%
EPS 3Y12.82%
EPS 5Y15.47%
EPS Q2Q%20.22%
Revenue 1Y (TTM)31.89%
Revenue growth 3Y17.48%
Revenue growth 5Y17.04%
Sales Q2Q%18.22%

3.2 Future

Based on estimates for the next years, HLNE will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.31% on average per year.
Based on estimates for the next years, HLNE will show a quite strong growth in Revenue. The Revenue will grow by 17.76% on average per year.
EPS Next Y27.02%
EPS Next 2Y17.51%
EPS Next 3Y17.31%
EPS Next 5YN/A
Revenue Next Year31.05%
Revenue Next 2Y19.45%
Revenue Next 3Y17.76%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 33.00 indicates a quite expensive valuation of HLNE.
Based on the Price/Earnings ratio, HLNE is valued a bit more expensive than 71.43% of the companies in the same industry.
When comparing the Price/Earnings ratio of HLNE to the average of the S&P500 Index (27.54), we can say HLNE is valued inline with the index average.
HLNE is valuated quite expensively with a Price/Forward Earnings ratio of 28.47.
Based on the Price/Forward Earnings ratio, HLNE is valued a bit more expensive than the industry average as 71.89% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of HLNE to the average of the S&P500 Index (23.99), we can say HLNE is valued inline with the index average.
Industry RankSector Rank
PE 33
Fwd PE 28.47

4.2 Price Multiples

HLNE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HLNE is cheaper than 60.83% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HLNE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 48.93
EV/EBITDA 27.6

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of HLNE may justify a higher PE ratio.
HLNE's earnings are expected to grow with 17.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.22
PEG (5Y)2.13
EPS Next 2Y17.51%
EPS Next 3Y17.31%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.29%, HLNE has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 9.57, HLNE is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.36, HLNE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.29%

5.2 History

On average, the dividend of HLNE grows each year by 26.37%, which is quite nice.
HLNE has been paying a dividend for over 5 years, so it has already some track record.
HLNE has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)26.37%
Div Incr Years7
Div Non Decr Years7

5.3 Sustainability

HLNE pays out 38.88% of its income as dividend. This is a sustainable payout ratio.
HLNE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP38.88%
EPS Next 2Y17.51%
EPS Next 3Y17.31%

HAMILTON LANE INC-CLASS A

NASDAQ:HLNE (12/26/2024, 1:23:43 PM)

154.09

+3.51 (+2.33%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)02-04 2025-02-04/amc
Inst Owners95.57%
Inst Owner Change4.69%
Ins Owners4.89%
Ins Owner Change0.06%
Market Cap8.54B
Analysts51.67
Price Target195.16 (26.65%)
Short Float %2.68%
Short Ratio2.76
Dividend
Industry RankSector Rank
Dividend Yield 1.29%
Dividend Growth(5Y)26.37%
DP38.88%
Div Incr Years7
Div Non Decr Years7
Ex-Date12-16 2024-12-16 (0.49)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)15.68%
Min EPS beat(2)-3.63%
Max EPS beat(2)34.99%
EPS beat(4)2
Avg EPS beat(4)10.13%
Min EPS beat(4)-24.34%
Max EPS beat(4)34.99%
EPS beat(8)4
Avg EPS beat(8)1.55%
EPS beat(12)8
Avg EPS beat(12)11.8%
EPS beat(16)12
Avg EPS beat(16)16.48%
Revenue beat(2)1
Avg Revenue beat(2)11.46%
Min Revenue beat(2)-3.38%
Max Revenue beat(2)26.31%
Revenue beat(4)2
Avg Revenue beat(4)11%
Min Revenue beat(4)-5.87%
Max Revenue beat(4)26.94%
Revenue beat(8)3
Avg Revenue beat(8)5.06%
Revenue beat(12)5
Avg Revenue beat(12)8.85%
Revenue beat(16)8
Avg Revenue beat(16)8.23%
PT rev (1m)15.26%
PT rev (3m)33.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.28%
EPS NY rev (1m)-2.06%
EPS NY rev (3m)-2.21%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)4.01%
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)-0.29%
Valuation
Industry RankSector Rank
PE 33
Fwd PE 28.47
P/S 13.17
P/FCF 48.93
P/OCF 46.83
P/B 14.08
P/tB 14.08
EV/EBITDA 27.6
EPS(TTM)4.67
EY3.03%
EPS(NY)5.41
Fwd EY3.51%
FCF(TTM)3.15
FCFY2.04%
OCF(TTM)3.29
OCFY2.14%
SpS11.7
BVpS10.94
TBVpS10.94
PEG (NY)1.22
PEG (5Y)2.13
Profitability
Industry RankSector Rank
ROA 12.76%
ROE 29.97%
ROCE 28.15%
ROIC 22.22%
ROICexc 28.44%
ROICexgc 29.96%
OM 45.03%
PM (TTM) 28.03%
GM N/A
FCFM 26.91%
ROA(3y)10.77%
ROA(5y)10.68%
ROE(3y)32.12%
ROE(5y)34.97%
ROIC(3y)19.34%
ROIC(5y)20.09%
ROICexc(3y)21.93%
ROICexc(5y)22.96%
ROICexgc(3y)23.08%
ROICexgc(5y)24.14%
ROCE(3y)24.51%
ROCE(5y)25.46%
ROICexcg growth 3Y13.41%
ROICexcg growth 5Y-9.75%
ROICexc growth 3Y12.7%
ROICexc growth 5Y-9.54%
OM growth 3Y-0.86%
OM growth 5Y1.44%
PM growth 3Y-2.38%
PM growth 5Y13.8%
GM growth 3YN/A
GM growth 5YN/A
F-Score9
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 1.12
Debt/EBITDA 0.65
Cap/Depr 85.68%
Cap/Sales 1.21%
Interest Coverage 250
Cash Conversion 60.55%
Profit Quality 96%
Current Ratio 0.92
Quick Ratio 0.92
Altman-Z 7.62
F-Score9
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)117.78%
Cap/Depr(5y)203.85%
Cap/Sales(3y)1.73%
Cap/Sales(5y)2.64%
Profit Quality(3y)128.03%
Profit Quality(5y)149.17%
High Growth Momentum
Growth
EPS 1Y (TTM)45.03%
EPS 3Y12.82%
EPS 5Y15.47%
EPS Q2Q%20.22%
EPS Next Y27.02%
EPS Next 2Y17.51%
EPS Next 3Y17.31%
EPS Next 5YN/A
Revenue 1Y (TTM)31.89%
Revenue growth 3Y17.48%
Revenue growth 5Y17.04%
Sales Q2Q%18.22%
Revenue Next Year31.05%
Revenue Next 2Y19.45%
Revenue Next 3Y17.76%
Revenue Next 5YN/A
EBIT growth 1Y33.86%
EBIT growth 3Y16.47%
EBIT growth 5Y18.73%
EBIT Next Year41.98%
EBIT Next 3Y22.43%
EBIT Next 5YN/A
FCF growth 1Y-26.41%
FCF growth 3Y-13.33%
FCF growth 5Y0.67%
OCF growth 1Y-24.47%
OCF growth 3Y-13.73%
OCF growth 5Y1.61%